Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation of tocilizumab and method for treating COVID-19 by inhalation

Formulation of tocilizumab and method for treating COVID-19 by inhalation

US Patent 11365248 · Granted Jun 21, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhalable formulation of a solution containing vilanterol trifenatate and umecli2023
Inhalation atomizer comprising a blocking function and a counter2022
Pharmaceutical formulation containing umeclidinium bromide and vilanterol trifen2022
Liposome formulation of fluticasone furoate and method of preparation2022
Liposome formulation of vilanterol trifenatate2021
Coated tablets of eszopiclone2015
Formulations, salts and polymorphs of transnorsertraline and uses thereof2015
Crystalline polymorphs of desvenlafaxine succinate and their preparations2010